Conduit Pharmaceuticals Inc. Cash Flow Reinvestment Rate
Latest as of June 2026:
0.95x
Conduit Pharmaceuticals Inc. cash flow reinvestment rate. Conduit Pharmaceuticals Inc. (CDT) has a Cash Flow Reinvestment Rate of 0.95x as of June 2026, reinvesting $40.66 Million (capex $40.66 Million ) from operating cash flow of $42.74 Million. Explore CDT operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.95x
(Capex + Investments) / Operating CF
Total Reinvested
$40.66 Million
Capex + Investments
Operating Cash Flow
$42.74 Million
USD
Capital Expenditures
$40.66 Million
USD
Conduit Pharmaceuticals Inc. Cash Flow Reinvestment Rate by Year (None–None)
Conduit Pharmaceuticals Inc. cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Conduit Pharmaceuticals Inc.. For the full cash flow conversion analysis, see Conduit Pharmaceuticals Inc. cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow